Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
about
Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisTargeting phosphatidylinositol-3-kinase pathway for the treatment of Philadelphia-negative myeloproliferative neoplasms.PAK1 is a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.Mastocytosis: a mutated KIT receptor induced myeloproliferative disorderFLT3 inhibitors: clinical potential in acute myeloid leukemia.DOCK2 interacts with FLT3 and modulates the survival of FLT3-expressing leukemia cells.Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia.O-GlcNAcylation of STAT5 controls tyrosine phosphorylation and oncogenic transcription in STAT5-dependent malignancies.Signaling coupled epigenomic regulation of gene expression.Phosphorylation of calcium/calmodulin-stimulated protein kinase II at T286 enhances invasion and migration of human breast cancer cells.Chronic FLT3-ITD Signaling in Acute Myeloid Leukemia Is Connected to a Specific Chromatin Signature.The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.A Forward Genetic Screen Targeting the Endothelium Reveals a Regulatory Role for the Lipid Kinase Pi4ka in Myelo- and Erythropoiesis.Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies.Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALLPharmacological inhibition of aberrant transcription factor complexes in inversion 16 acute myeloid leukemia
P2860
Q26797245-D6442603-BD94-49AF-BC92-895FB590C66FQ35727453-BCA22924-3463-4806-BA8B-970BAA6F3C62Q36000867-4F26F0DB-715F-40B9-9491-E262DCAFFD07Q36210845-798B80E6-C3CC-404B-B92C-72827A8E42FBQ37638749-A3C3A814-1146-48E5-B5BF-437C4E3774EEQ37675217-9A92223B-84D2-4089-AB1A-7480ED2B1422Q38429500-277E9DA1-0EB0-43EB-9384-E81C4F499DE0Q39028183-6E348633-CB7B-45A6-B23D-CC73F72FFAC6Q39398333-A310BC9A-F86D-4B64-8037-06815E314C25Q41039207-6E3B6D1A-CBC6-442E-808B-7B38D9765087Q41089332-E1D856F4-354D-413A-B383-F1DE27A5E545Q49176545-F5EA2B3B-7C4F-490D-AAA1-F687F5398503Q49547319-077F47E0-F49E-4F9A-B5F4-5F69FDCD7C16Q55496770-98362770-FFE8-48D3-9368-7D6D7618E470Q57287566-8A7A4BB1-23FC-4988-BCCC-BACB368D141EQ58604425-53F2B463-C88B-4095-9223-D4E5CAD98783
P2860
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@ast
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@en
type
label
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@ast
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@en
prefLabel
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@ast
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@en
P2093
P2860
P1433
P1476
Regulation of Stat5 by FAK and PAK1 in Oncogenic FLT3- and KIT-Driven Leukemogenesis
@en
P2093
Anindya Chatterjee
Baskar Ramdas
Catherine C Smith
Emily R Waskow
H Scott Boswell
Holly Martin
Kevin D Bunting
Michihiro Kobayashi
Raghuveer Singh Mali
P2860
P304
P356
10.1016/J.CELREP.2014.10.039
P407
P577
2014-11-13T00:00:00Z